Abstract
Phospholipase A2 (PLA2) enzymes are implicated in several pathological conditions such as arthritis, cardiovascular diseases, and diabetes. It is highly important to regulate their activity and develop PLA2 inhibitors as new agents to treat inflammatory diseases.
Funding Information
  • not funded

This publication has 125 references indexed in Scilit: